← Leaderboards
Shaharyar M Khan
Gencia Corporation
$505,219
Attributed
$505,219
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $140K · FY2007–09$200K$150K$100K$50K$0
'07
'08
'09
Funding mix
By agency
NIH$505,219 · 3
By mechanism
R21$277,200 · 1
R43$228,019 · 2
Top collaborators
No co-investigators on record.
Most similar at Gencia Corporation
Same institution · by research overlap
- Rafal M Smigrodzki$1,294,657
- Shaharyar Khan$196,192
Others in their field
Top investigators on “Transfection”
- David Heimbrook · Leidos Biomedical Research, Inc.$94,306,630
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$39,277,975
- Barton F Haynes · Duke University$19,824,751
- William W Hauswirth · University Of Florida$19,491,817
- Michael P Snyder · Yale University$14,582,826
- Larry Arthur$12,814,310
Research focus
TransfectionCell LineAgingMitochondrial GenomeMalignant NeoplasmsMitochondrial Dna MutationIn VitroCell DeathGenomeInvestigationLeber&AposLengthMitochondriaMitochondrial DiseasesDiabetes MellitusEncephalopathiesBaseAchievementAffectEngineeringCellsInheritedDeafnessIn Vivo
Grant awards (4)
Mitochondrial Genome Replacement Therapy (MGRT)$122,986
R43 · FY2009 · GM · contact PI
Protein Transduction Mediated Delivery to Mitochondria for Neurodegenerative Dise$137,200
R21 · FY2008 · EY · contact PI
Protein Transduction Mediated Delivery to Mitochondria for Neurodegenerative Dise$140,000
R21 · FY2007 · EY · contact PI
Mitochondrial DNA in Human Aging$105,033
R43 · FY2003 · AG